Centessa Pharmaceuticals Q1 2025 10-Q Filing
Ticker: CNTA · Form: 10-Q · Filed: May 14, 2025 · CIK: 1847903
| Field | Detail |
|---|---|
| Company | Centessa Pharmaceuticals PLC (CNTA) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Centessa Pharma's Q1 2025 10-Q is in. Check financials.
AI Summary
Centessa Pharmaceuticals plc filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and strategic developments are outlined within the report.
Why It Matters
This filing provides investors with the latest financial health and operational status of Centessa Pharmaceuticals, crucial for understanding its current market position and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Centessa faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-01-01 — Reporting Period Start Date (Indicates the start of the financial quarter being reported.)
- 2024-12-31 — Prior Period End Date (Provides a comparison point to the previous fiscal year-end.)
Key Players & Entities
- Centessa Pharmaceuticals plc (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250514 (date) — Filing date
FAQ
What is the primary purpose of this 10-Q filing?
This 10-Q filing provides Centessa Pharmaceuticals plc's quarterly financial statements and management's discussion and analysis for the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q filing was filed on May 14, 2025.
What fiscal period does this 10-Q cover?
This 10-Q covers the fiscal period ending March 31, 2025.
What is the company's Standard Industrial Classification (SIC) code?
Centessa Pharmaceuticals plc's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What are some of the financial statement line items mentioned in the filing?
The filing mentions line items such as Common Stock, Additional Paid-In Capital, Accumulated Other Comprehensive Income, and Retained Earnings for various periods.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Centessa Pharmaceuticals plc (CNTA).